Growth response in Turner syndrome with recombinant human growth hormone therapy.
Southeast Asian J Trop Med Public Health
;
1995 ; 26 Suppl 1(): 142-5
Artigo
em Inglês
| IMSEAR
| ID: sea-33106
ABSTRACT
Ten Turner syndrome girls whose mean age was 10.9 +/- 2.7 years were treated with recombinant human growth hormone (rhGH), dose 0.6 U/kg/week. Five of them had classical 45, XO karyotype. The mean height velocity increased from 2.8 +/- 1.3 cm/year before treatment to 6.1 +/- 2.06 cm/year after treatment for a period of 1.4 years. The response of treatment correlated well with pretreatment height velocity (<3 cm/year) but not with karyotype. However, the response has been decreasing and an increased dose after the first year of treatment is recommended.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Testes de Função Tireóidea
/
Fatores de Tempo
/
Síndrome de Turner
/
Estatura
/
Desenvolvimento Ósseo
/
Proteínas Recombinantes
/
Feminino
/
Humanos
/
Hemoglobinas Glicadas
/
Hormônio do Crescimento
Tipo de estudo:
Estudo observacional
/
Estudo prognóstico
Idioma:
Inglês
Revista:
Southeast Asian J Trop Med Public Health
Ano de publicação:
1995
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS